Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada

BACKGROUND: Ticagrelor demonstrated a significant reduction in major cardiac events in patients with acute coronary syndrome (ACS) compared with clopidogrel in the Platelet Inhibition and Patient Outcomes (PLATO) trial. The objective of this study was to assess the cost-effectiveness of ticagrelor c...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Grima, Daniel T, Brown, Stephen T, Kamboj, Laveena, Bainey, Kevin R, Goeree, Ron, Oh, Paul, Ramanathan, Krishnan, Goodman, Shaun G
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2014
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3908913/
https://ncbi.nlm.nih.gov/pubmed/24493930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S51052
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi